Which
oral drug for treating hyperglycemia can delay the absorption of
carbohydrate and lower postprandial glycemic excursion: ____
A: sulfonylureas
B: metformin
C: acarbose
D: insulin
E: DPP-IV
inhibitor
oral drug for treating hyperglycemia can delay the absorption of
carbohydrate and lower postprandial glycemic excursion: ____
A: sulfonylureas
B: metformin
C: acarbose
D: insulin
E: DPP-IV
inhibitor
举一反三
- Which<br/>oral drug for treating hyperglycemia can delay the absorption of<br/>carbohydrate and lower postprandial glycemic excursion: ( <br/>) A: Sulfonylureas B: Metformin C: Acarbose D: Insulin E: Thiazolidinediones
- Oral<br/>hypoglycemic agents EXCEPT() A: Sulfonylureas B: Biguanides C: Thiazolidinediones D: Insulin E: α-glucosidase inhibitors
- Carbohydrate<br/>having high glycemic index leads to () A: obesity B: insulin<br/>resistance C: diabetes<br/>mellitus type 2 D: all<br/>of the above
- The<br/>bioavailability is() A: the<br/>quantity of drug absorbed after oral administration B: the<br/>rate of drug absorbed after oral administration C: the<br/>ratio of AUC(oral)/AUC(intravenous) D: the<br/>ratio of AUC (intravenous)/AUC(oral) E: the<br/>area under curve of oral administration
- Which of the<br/>following clinical manifestations of drug allergy does not belong to<br/>type IV allergy ____? A: eczematous drug<br/>eruption B: Morbilliform drug<br/>eruption C: Exfoliative<br/>dermatitis D: Urticaria